Sequential phase II Southwest Oncology Group studies (S0112 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with ciclosporin, in older patients with previously untreated acute myeloid leukaemia

Thomas R. Chauncey, Holly Gundacker, Mazyar Shadman, Alan F. List, Shaker R. Dakhil, Harry P. Erba, Marilyn L. Slovak, I. Ming Chen, Cheryl L. Willman, Kenneth J. Kopecky, Frederick R. Appelbaum

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Sequential phase II Southwest Oncology Group studies (S0112 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with ciclosporin, in older patients with previously untreated acute myeloid leukaemia'. Together they form a unique fingerprint.

Medicine & Life Sciences